Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
18.38
+0.52 (2.91%)
At close: Aug 14, 2026, 4:00 PM EDT
18.26
-0.12 (-0.65%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $6.43 billion as of August 14, 2026. Its market cap has increased by 1,298.91% in one year.
Market Cap
6.43B
Enterprise Value
6.09B
1-Year Change
1,298.91%
Ranking
Category
Stock Price
$18.38
ChartMarket Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $6.43B, an increase of 245.94%. That is a compound annual growth rate of 27.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 6.43B | 509.11% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 6.68B |
| Cogent Biosciences | 6.54B |
| Mirum Pharmaceuticals | 6.52B |
| Dianthus Therapeutics | 6.45B |
| Scholar Rock Holding | 6.39B |
| Belite Bio | 6.30B |
| Caris Life Sciences | 6.16B |
| Xenon Pharmaceuticals | 6.04B |